Firmly focusing on the core business direction, LINKLOGIS-W (09959) achieved a main operating income and profit of 375 million yuan in the first half of the year.
Lianyirong Technology-W (09959) announced its interim results for the six months ending on June 30, 2025. The group achieved...
LINKLOGIS-W (09959) announced its interim performance for the six months ending on June 30, 2025. The group achieved a main business revenue and profit of RMB 375 million (the unit is the same), with a gross profit of RMB 210 million. The net loss attributable to equity shareholders of the company for the period was RMB 380 million.
In the first half of 2025, the group firmly focused on its core business direction, accelerating business model transformation and upgrading in the context of global macroeconomic fluctuation and industry continuous adjustment, continuously improving operational efficiency and cash flow, and achieving quality and stable development. During the reporting period, the total supply chain assets processed by our technology solutions amounted to RMB 203.6 billion. The multi-level circulation cloud continued to maintain strong growth, with the size of supply chain assets processed growing by 54.4% year-on-year to RMB 133.2 billion. Due to our accelerated adjustment of product and customer structures, promotion of organizational structure optimization, improvements in business structure, and reduction in operating expenses, revenue and profit were under pressure. In the first half of 2025, our revenue and profit reached RMB 375 million, a decrease of 9.3% year-on-year. In addition, due to the impact of complex economic environment changes, the group made more cautious provision for impairment of historical bridging supply chain assets. Our adjusted net loss for the first half of 2025 was RMB 372 million. As of June 30, 2025, our total cash and cash equivalents and restricted cash amounted to RMB 5.378 billion, an increase of RMB 3.06 billion compared to the balance as of December 31, 2024.
In the first half of 2025, we continued to deepen our focus on key industry clients, driving ecological cross-sales through the customer value flywheel and achieving quality customer growth. During the reporting period, our supply chain finance technology solutions added 244 core enterprise and financial institution clients, bringing the total number of clients to 1,352, an increase of 22% compared to 2024. We seized the opportunity of central state-owned enterprise treasury system construction, accelerated the conversion and implementation of core enterprise self-built platform projects, and deeply focused on key industry client value in "big infrastructure + new energy + high-end manufacturing," driving double-digit steady growth in the number of core enterprise clients and asset processing scale. With optimized customer structure and improved satisfaction, our overall customer retention rate increased from 96% in 2024 to 99%.
Related Articles

AUSTAR (06118) released its interim performance results, with a net profit attributable to shareholders of 24.99 million yuan, an increase of 325.37% year-on-year.

I-CABLE COMM (01097) announces interim performance with a net loss of approximately HK$217 million, a year-on-year decrease of 14.95%.
.png)
Shanghai Fosun Pharmaceutical(02196): The drug registration application for Injection of Chlorhexidine Hydrochloride was accepted by the National Medical Products Administration.
AUSTAR (06118) released its interim performance results, with a net profit attributable to shareholders of 24.99 million yuan, an increase of 325.37% year-on-year.

I-CABLE COMM (01097) announces interim performance with a net loss of approximately HK$217 million, a year-on-year decrease of 14.95%.

Shanghai Fosun Pharmaceutical(02196): The drug registration application for Injection of Chlorhexidine Hydrochloride was accepted by the National Medical Products Administration.
.png)
RECOMMEND

Analysts Respond to Trump’s Dismissal of Fed Governor Cook as a Further Assault on Central Bank Independence
26/08/2025

U.S. Proposes Including Copper, Silicon, Silver on 2025 Critical Minerals List Amid Supply Chain Concerns
26/08/2025

Trump Vows to Slash U.S. Drug Prices by Up to 1500%, Triggering Sell-Off in Pharma Stocks
26/08/2025